Company: RGNT
Filing Date: 2025-10-24
Form Type: F-1/A
Source: 0001213900-25-101900
Chunk: 46

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-10-24
Form: F-1/A
Chunk 46
---
 have adequate remedies for any such breach or violation. If any of our
intellectual property or confidential or proprietary information, such as our trade secrets, were to be disclosed or misappropriated,
or if any such information was independently developed by a competitor, it could have a material adverse effect on our competitive position,
business, financial condition, results of operations and prospects.

If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest and our competitive position may be harmed.

We rely on our trademarks,
trade names and brand names to distinguish our products from the products of our competitors, and have registered or applied to register
many of these trademarks. There can be no assurance that our trademark applications will be approved. Third parties may also oppose our
trademark applications or otherwise challenge our use of the trademarks. In the event that our trademarks are successfully challenged,
we could be forced to rebrand our products, which could result in loss of brand recognition, and could require us to devote resources
to advertising and marketing new brands. Further, there can be no assurance that competitors will not infringe our trademarks or that
we will have adequate resources to enforce our trademarks. We also license third parties to use our trademarks. In an effort to preserve
our trademark rights, we enter into license agreements with these third parties, which govern the use of our trademarks and require our
licensees to abide by quality control standards with respect to the goods and services that they provide under our trademarks. Although
we make efforts to monitor the use of our trademarks by our licensees, there can be no assurance that these efforts will be sufficient
to ensure that our licensees abide by the terms of their licenses. In the event that our licensees fail to do so, our trademark rights
could be diluted. Any of the foregoing could have a material adverse effect on our competitive position, business, financial condition,
results of operations and prospects.

Patent terms may not be sufficient to effectively protect our products and business for an adequate period of time.

Patents have a limited lifespan.
In the United States, the natural expiration of a patent is generally 20 years after its first effective non-provisional filing date.
Although various extensions may be available, the term of a patent, and the protection it affords, is limited. Even if patents covering
our technologies and their uses are obtained, once the patent has expired, we may be open to competition. In addition, although upon
issuance in